HCV Advocate

Researchers assessed hepatitis C virus (HCV) prevalence among transwomen in San Francisco via performing a cross-sectional survey. Further, they assessed the indicators of engagement in HCV care.

California has long been a leader on forward-thinking policies, but the state is falling behind in addressing a major public health crisis: the continuing spread of HIV, hepatitis C (HCV), and sexually transmitted infections (STIs).

A small pilot study of hepatitis C treatment in pregnant women found that that the treatment was effective in achieving hepatitis C cure and identified no safety concerns associated with treatment. #CROI2019

The first study to evaluate the cost-effectiveness of hepatitis C virus (HCV) screening among pregnant women in the US in the era of direct-acting antiviral (DAA) treatment demonstrates that it would be highly cost effective, even in states with low HCV prevalence.

FDA takes new steps to broaden patient participation in cancer clinical trials, advancing policies to promote inclusion of pediatric patients and patients with medical conditions that can occur alongside cancer

Two states fighting an escalating hepatitis C crisis will soon pay a flat fee for unlimited drugs Netflix style to treat prisoners and low-income residents suffering from the deadly liver disease, with the goal of all but eliminating the infection.

Note: chlorcyclizine is an antihistamine used to treat allergies, cough, and nasal congestion. Patients with chronic hepatitis C virus (HCV), chlorcyclizine HCl plus ribavirin showed some anti-HCV effects

An analysis of patients with HIV who were being treated for hepatitis C virus infection found that 7% failed direct-acting antiviral therapy, and that mental illness and ongoing illicit drug use often predicted failure, researchers reported.

Note: My opinion is that there will be plenty of research dollars left over even if price controls are put into place. Alan

Note: Not sure what this study really means for the long-term since the study follow-up period was only 36 weeks. -Alan

Large-scale study confirms antiviral therapy should be systematically offered to hepatitis B- and C-infected kidney transplant recipients.

Sometimes I was so tired I could barely take off my shoes. In a way, it was a relief to know there really was something wrong with me, says Wendy Overy. For Aucklander Wendy Overy, being cured of hepatitis C has been life-changing. I had all this energy I’d forgotten about, it was amazing, says Overy, who was cured during a trial of the drug sofosbuvir.

More than two-thirds of patients with hepatitis C who visited a Federally Qualified Health Center in Philadelphia were linked to care.